Page last updated: 2024-10-25

damnacanthal and Ovarian Neoplasms

damnacanthal has been researched along with Ovarian Neoplasms in 1 studies

damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"Damnacanthal is an anthraquinone derivative with anti-cancer pharmacological properties."1.72Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy. ( Han, B; Jiang, W; Lan, J; Li, H; Li, R; Lin, X; Liu, F; Su, B; Xu, H; Yang, D; Yang, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, R1
Li, H1
Lan, J1
Yang, D1
Lin, X1
Xu, H1
Han, B1
Yang, M1
Su, B1
Liu, F1
Jiang, W1

Other Studies

1 other study available for damnacanthal and Ovarian Neoplasms

ArticleYear
Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 100

    Topics: Animals; Anthraquinones; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cisplatin; Fema

2022